Very early researchEnded earlyNCT03507374
What this trial is testing
PCSK9 Inhibition in Patients With Symptomatic Intracranial Atherosclerosis
Who this might be right for
StrokeIntracranial AtherosclerosisIntraplaque Hemorrhage
University of Utah 20